South Carolina Court Heard Opioid Insurance Case
The state Supreme Court will decide if insurance policies must cover costs for over 350 opioid-related lawsuits.
Updated on Oct. 14, 2026 in Substance Abuse
Live Poll
Should insurance companies be required to cover legal costs for drug companies facing opioid-related lawsuits?
The South Carolina Supreme Court has agreed to determine if insurance policies cover legal costs for opioid litigation. The case hinges on how contracts define bodily injury in relation to pending claims against JM Smith Corp.
Why it matters
The ruling will clarify if pharmaceutical companies can access insurance coverage for their defense against hundreds of opioid-related lawsuits. This decision carries significant implications for liability and financial risk management in the pharmaceutical sector.
JM Smith Corp. currently faces 350 opioid-related lawsuits that remain active in various courts. The South Carolina Supreme Court must now evaluate whether these claims trigger insurance coverage based on contractual definitions of bodily injury.
The players
South Carolina Supreme Court
This is the highest court in the state and the final arbiter for interpretations of state law and insurance contracts.
JM Smith Corp.
This is a corporation currently facing hundreds of legal challenges related to its role in the pharmaceutical industry.
Jacquelyn D. Austin
She serves as a federal judge for the US District Court for the District of South Carolina.
The details
Judge Jacquelyn D. Austin of the US District Court for the District of South Carolina formally certified the question to the state's high court. The justices will analyze if the specific language in insurance policies limits damages to individual claimants or if it extends to broader liability litigation.
Timeline
Judge Jacquelyn D. Austin issued the certification order on October 13, 2026.
Health Landscape
This case follows similar litigation patterns seen in Florida and Georgia, where high courts are also debating whether opioid lawsuits fall under traditional bodily injury insurance definitions. These regional rulings will collectively shape the legal standards for pharmaceutical liability across the country.
This legal outcome could significantly affect the resources available to pharmaceutical distributors and, by extension, the broader healthcare infrastructure in the state. Residents should note that the resolution of these insurance disputes may impact how future opioid-related settlements are funded and managed.
The takeaway
The court's decision will establish a critical precedent for how insurance companies and pharmaceutical firms navigate liability for mass-tort litigation. Industry observers should watch for how this interpretation of bodily injury language aligns with or deviates from similar rulings in other states.
Further reading
For more information on legal trends, visit the South Carolina Substance Abuse section.
Source note: This article includes information reported by Bloomberglaw.
Live Poll
Should insurance companies be required to cover legal costs for drug companies facing opioid-related lawsuits?
